Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS) : Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs
The study investigators are interested in learning more about how drugs, that are given to children by their health care provider, act in the bodies of children and young adults in hopes to find the most safe and effective dose for children. The primary objective of this study is to evaluate the PK of understudied drugs currently being administered to children per SOC as prescribed by their treating provider..
Medienart: |
Klinische Studie |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
ClinicalTrials.gov - (2024) vom: 01. Apr. Zur Gesamtaufnahme - year:2024 |
---|
Sprache: |
Englisch |
---|
Links: |
Volltext [kostenfrei] |
---|
Anmerkungen: |
Source: Link to the current ClinicalTrials.gov record., First posted: February 20, 2020, Last downloaded: ClinicalTrials.gov processed this data on April 03, 2024, Last updated: April 03, 2024 |
---|
fisyears: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
CTG000193852 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | CTG000193852 | ||
003 | DE-627 | ||
005 | 20240403010455.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240403s2024 xx |||||o 00| ||eng c | ||
035 | |a (DE-627)CTG000193852 | ||
035 | |a (UBBS_Klinische_Studien)NCT04278404 | ||
035 | |a (UBBS_Klinische_Studien)Pro00103838 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
245 | 1 | 0 | |a Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS) |b Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Source: Link to the current ClinicalTrials.gov record., First posted: February 20, 2020, Last downloaded: ClinicalTrials.gov processed this data on April 03, 2024, Last updated: April 03, 2024 | ||
520 | |a The study investigators are interested in learning more about how drugs, that are given to children by their health care provider, act in the bodies of children and young adults in hopes to find the most safe and effective dose for children. The primary objective of this study is to evaluate the PK of understudied drugs currently being administered to children per SOC as prescribed by their treating provider. | ||
650 | 2 | |a Infections | |
650 | 2 | |a Communicable Diseases | |
650 | 2 | |a Coronavirus Infections | |
650 | 2 | |a Urinary Tract Infections | |
650 | 2 | |a Pulmonary Arterial Hypertension | |
650 | 2 | |a Bronchopulmonary Dysplasia | |
650 | 2 | |a Down Syndrome | |
650 | 2 | |a Menorrhagia | |
650 | 2 | |a Hypertension | |
650 | 2 | |a Hemostatic Disorders | |
650 | 2 | |a Mucocutaneous Lymph Node Syndrome | |
650 | 2 | |a Blood Coagulation Disorders | |
650 | 2 | |a Hyperphosphatemia | |
650 | 2 | |a Hypokalemia | |
650 | 2 | |a Adrenal Insufficiency | |
650 | 2 | |a Hyperaldosteronism | |
650 | 2 | |a Syndrome | |
650 | 2 | |a Hemorrhage | |
650 | 2 | |a Attention Deficit Disorder with Hyperactivity | |
650 | 4 | |a Study Type: Observational | |
650 | 4 | |a Recruitment Status: Recruiting | |
650 | 4 | |a 610 | |
773 | 0 | 8 | |i Enthalten in |t ClinicalTrials.gov |g (2024) vom: 01. Apr. |
773 | 1 | 8 | |g year:2024 |g day:01 |g month:04 |
856 | 4 | 0 | |u https://clinicaltrials.gov/show/NCT04278404 |z kostenfrei |3 Volltext |
912 | |a GBV_CTG | ||
951 | |a AR | ||
952 | |j 2024 |b 01 |c 04 |